West Nile Virus positivity amongst Canadian blood donors and effectiveness of off‐season screening
Transfusion · 2025
DOI: 10.1111/trf.18326 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transfusion, 2025. Verfasst von Carmen L Charlton und 8 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology, Donation Policy & Studies, Canadian Blood Services, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Blood Donors, West Nile virus, West Nile Fever, Donor Selection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
We sought to examine the prevalence of West Nile Virus (WNV) nucleic acid test (NAT) positivity over time in Canadian blood donors, examine the level of false‐positive NAT screening, and understand the effectiveness of travel‐related testing outside of WNV seasonality in Canada. Study Design and Methods All blood donations in Canada (except Québec) between 2018 and 2023 were tested by the Roche Cobas WNV‐NAT assay during the summer–fall season by Canadian Blood Services. Testing for recent travel outside Canada was performed in the winter–spring season. All 2023 WNV‐NAT‐positives were confirmed by two independent WNV‐specific polymerase chain reaction (PCRs).
Results
While WNV positivity varied by location and time, no increasing trend of positivity was observed over the 6‐year study period. No WNV‐NAT‐positive donors with a history of recent travel outside of Canada in the winter–spring season were identified by donor screening (2018–2023). In total, 2,454,102 samples were tested during summer months and 267,988 in winter months. In 2023, WNV‐specific PCR confirmed 10 of 13 (76.9%) screening WNV‐NATs. Recent Japanese Encephalitis Virus (JEV) vaccination was identified as a potential false positive for initial WNV screening results.
Discussion
Between 2018 and 2023, WNV‐NAT positivity amongst Canadian blood donors remained stable, with no evidence of an increasing positivity trend. The utility of off‐season travel‐related testing may be limited, as no donors were identified during the six‐year study timeframe. Finally, confirmation testing using WNV‐specific PCR is recommended to identify true cases and to limit misidentification of other genetically similar viruses, such as JEV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microbiology, Donation Policy & Studies, Canadian Blood Services, Edmonton, Alberta, Canada.
- Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
- National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
- Canadian Blood Services, Brampton, Ontario, Canada.
- Canadian Blood Services, Vancouver, British Columbia, Canada.
- Epidemiology and Surveillance, Donation Policy & Studies, Canadian Blood Services, Ottawa, Ontario, Canada.
ORCID-Profile: Carmen L Charlton, Steven J Drews
Zitieren
APA
Charlton, C. L., Drews, S. J., Makowski, K., Hawes, G., Cranney, C., Robinson, A., Wood, H., Bigham, M., & O'Brien, S. F. (2025). West Nile Virus positivity amongst Canadian blood donors and effectiveness of off‐season screening. Transfusion. https://doi.org/10.1111/trf.18326
Vancouver
Charlton CL, Drews SJ, Makowski K, Hawes G, Cranney C, Robinson A, et al. West Nile Virus positivity amongst Canadian blood donors and effectiveness of off‐season screening. Transfusion. 2025. doi:10.1111/trf.18326
BibTeX
@article{Charlton2025,
author = {Charlton, Carmen L and Drews, Steven J and Makowski, Kai and Hawes, Gordon and Cranney, Cynthia and Robinson, Alyssia and Wood, Heidi and Bigham, Mark and O'Brien, Sheila F},
title = {West Nile Virus positivity amongst Canadian blood donors and effectiveness of off‐season screening},
journal = {Transfusion},
year = {2025},
doi = {10.1111/trf.18326}
}
EUVIMED